JP2005527834A5 - - Google Patents

Download PDF

Info

Publication number
JP2005527834A5
JP2005527834A5 JP2004509410A JP2004509410A JP2005527834A5 JP 2005527834 A5 JP2005527834 A5 JP 2005527834A5 JP 2004509410 A JP2004509410 A JP 2004509410A JP 2004509410 A JP2004509410 A JP 2004509410A JP 2005527834 A5 JP2005527834 A5 JP 2005527834A5
Authority
JP
Japan
Prior art keywords
solution
patient
blood
nitric oxide
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004509410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005527834A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/013409 external-priority patent/WO2003102575A1/en
Publication of JP2005527834A publication Critical patent/JP2005527834A/ja
Publication of JP2005527834A5 publication Critical patent/JP2005527834A5/ja
Pending legal-status Critical Current

Links

JP2004509410A 2002-05-29 2003-05-27 血液ガス中の一酸化窒素の測定およびそれに基づく処置 Pending JP2005527834A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38359502P 2002-05-29 2002-05-29
PCT/US2003/013409 WO2003102575A1 (en) 2002-05-29 2003-05-27 Measuring nitric oxide in blood gases and treatments based thereon

Publications (2)

Publication Number Publication Date
JP2005527834A JP2005527834A (ja) 2005-09-15
JP2005527834A5 true JP2005527834A5 (cg-RX-API-DMAC7.html) 2006-07-13

Family

ID=29711927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004509410A Pending JP2005527834A (ja) 2002-05-29 2003-05-27 血液ガス中の一酸化窒素の測定およびそれに基づく処置

Country Status (6)

Country Link
US (1) US20060088942A1 (cg-RX-API-DMAC7.html)
EP (1) EP1514103A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005527834A (cg-RX-API-DMAC7.html)
AU (1) AU2003232019A1 (cg-RX-API-DMAC7.html)
CA (1) CA2487719A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003102575A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295697B2 (en) 2002-12-12 2009-12-24 Duke University Forming iron nitrosyl hemoglobin
WO2005004884A2 (en) 2003-07-09 2005-01-20 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2009029836A2 (en) 2007-08-31 2009-03-05 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes
RU2449783C2 (ru) * 2010-08-02 2012-05-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ коррекции l-name индуцированного дефицита оксида азота l-норвалином в эксперименте
JP6389125B2 (ja) * 2011-11-07 2018-09-12 ザ ジェネラル ホスピタル コーポレイション 赤血球の処理法
RU2500040C1 (ru) * 2012-04-12 2013-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ коррекции l-name индуцированного дефицита оксида азота комбинацией тадалафила и l-норвалина в эксперименте

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69127756T2 (de) * 1990-12-05 1998-02-05 The General Hospital Corp., Charlestown, Mass. Verwendung von no zur behandlung oder prävention der bronchokonstriktion
US5459076A (en) * 1992-04-22 1995-10-17 Brigham And Women's Hospital Method for detecting nitric oxide, nitrosonium equivalents, S-nitrosothiols and S-nitroso-proteins in biological systems
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US6153186A (en) * 1995-09-15 2000-11-28 Duke University Medical Center Red blood cells loaded with S-nitrosothiol and uses therefor
US6916471B2 (en) * 1995-09-15 2005-07-12 Duke University Red blood cells loaded with S-nitrosothiol and uses therefor
US6197745B1 (en) * 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
US5869539A (en) * 1996-04-17 1999-02-09 Board Of Regents, The University Of Texas System Emulsions of perfluoro compounds as solvents for nitric oxide (NO)
US5885842A (en) * 1996-11-08 1999-03-23 Medinox, Inc. Methods for the detection of nitric oxide in fluid media
CA2278784A1 (en) * 1997-02-06 1998-08-13 Jonathan S. Stamler No-modified hemoglobins and uses therefor
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
AU2003210952A1 (en) * 2002-02-08 2003-09-02 Gambro, Inc. Nitric oxide in a pathogen inactivation process

Similar Documents

Publication Publication Date Title
Watkinson et al. Myocardial adenosine formation with increased cardiac performance in the dog
Sinclair et al. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury
EP3731913A1 (en) Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension
JP2011105728A5 (cg-RX-API-DMAC7.html)
WO2003094932A1 (en) Carbon monoxide as a biomarker and therapeutic agent
US20100137380A1 (en) Hypoxic conditioning in patients with exercise limiting conditions
Coghill et al. Individual differences in pain sensitivity: implications for treatment decisions
Butler et al. Circulating catecholamines and swimming performance in the Atlantic cod, Gadus morhua
Pypendop et al. Hemodynamic effects of sevoflurane in cats
US6613342B2 (en) System and method for treating kidney diseases in diabetic and non-diabetic patients
Rave et al. Inhaled micronized crystalline human insulin using a dry powder inhaler: dose‐response and time‐action profiles 1
Waterman et al. Some physiological effects of ketamine in sheep
Bastard et al. Circulatory effects of isoflurane in patients with ischemic heart disease: a comparison with halothane
Mink et al. Early but not delayed continuous arteriovenous hemofiltration improves cardiovascular function in sepsis in dogs
RU2039555C1 (ru) Способ лечения ожогового шока
Astin et al. The action of carbon dioxide on constricted airways
Hardwick et al. Kidney oxygen availability
Yu et al. Intratracheal injection of nitric oxide, generated from air by pulsed electrical discharge, for the treatment of pulmonary hypertension in awake ambulatory lambs
CN214342791U (zh) 一种注射器
Larcombe et al. Partial amelioration of a chronic cigarette-smoke-induced phenotype in mice by switching to electronic cigarettes
Purdell-Lewis Studies of fentanyl-supplemented anaesthesia: Effect of naloxone on the circulation and respiration
Suzuki et al. Effects of inspiratory oxygen concentration and ventilation method on a model of hemorrhagic shock in rats
Nair et al. Laparoscopic adrenalectomy in a post-pneumonectomy state
Yao et al. Simulation of oxygen supply in the tissue and its relationship with Lung Qi-Deficiency
US20100170505A1 (en) Device for enhancing well-being